Checkpoint Inhibition

Slides:

Advertisements

Similar presentations

Hawaii State EMS Chest Pain Standing Order Review Prepared for Honolulu Emergency Medical Services Presented by Dr. Joseph Lewis, M.D., Medical Director,

Advertisements

Cardiac Pathology in Athletes. Sudden Death About 25 young patients die each year nationally in sudden-initially unexplained deaths on the field in all.

2. What are the common and uncommon symptoms of MVP?

Epidemiology Incidence is unknown although some have estimated 1-2% of all patients presenting with “ACS” Mean age is and rarely has been reported.

Upfront Combination Therapy vs Step-Up Approach for PAH:

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Immunotherapies: Key Considerations in the Identification and Management of irAEs.

CDK 4 and 6 Inhibitors in HR-Positive Breast Cancer: Implementing Paradigms in Clinical Practice.

COPD by the Guidelines.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

Advances in Managing Inhibitors in Patients With Hemophilia A

Cardiac Troponin.

Effective Management of Psoriatic Arthritis: Tailoring Treatments

New Therapies for Hyperkalemia Across the Continuum of Care

Progression After Cancer Immunotherapy in Advanced NSCLC

Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.

The Tumor Microenvironment

PCP Perspectives Clinical Considerations in Hyperkalemia

The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.

Activity Goals. Activity Goals Discussion Topics.

Expanding Treatment Horizons in Head and Neck Cancer: TRK Inhibitors

Follow-Up of the Patient After PE

Optimizing Management of Advanced Bladder Cancer

Checkpoint Inhibition

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

The Nurse View: Top Ten Things to Know About Immune-Mediated Adverse Events.

Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.

Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.

Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Skin.

Managing Adverse Events With New Oral Therapies in CLL

Immunotherapy for cSCC

HIV Treatment: What Can You Do to Get and Keep Patients in Care?

Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin.

Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.

Hidden in Plain Sight: Disrupted Sleep in Patients With Pain

Managing Polycythemia Vera in the Community Setting

Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma

Improving Outcomes in Psoriatic Arthritis

Evolving Concepts in the Management of Head and Neck Cancers

Case Study 56-year-old Presents With 1 Year of Worsening Dyspnea

Cost-effective Approaches to Diagnosing Syncope

Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.

Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.

Patient Questions and Expert Answers in Psoriasis:

Severe Asthma and Comorbidities

Management of Advanced Pancreatic Adenocarcinoma

Insulin in Diabetes Management: Effective Patient Selection Is Key

Optimizing Joint Health in Hemophilia

Possible Causes of imAEs

Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.

Novel Concepts in the Management of RCC

From Adjuvant to Metastatic in Melanoma

The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.

Activity Goals. Clinical Considerations in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.

Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department J.M. Poldervaart,

AMD Therapy: Where Are We Now and Where Are We Going?

Checkpoint Inhibitors in First-Line Advanced NSCLC

The Nurse View: Spotlight on EGFR-Mutated NSCLC

MS, Age, and Immune Function

The Building Blocks of Homocystinuria and Homocysteinemia Management

Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.

Immune Checkpoint Inhibitors in Lung Cancer

The Nurse View.

The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.

Shared-Decision Making in Dyslipidemia

Overview of irAEs. Management of Immune-Related Adverse Events for Patients Receiving Checkpoint Inhibitor Therapy.

Interprofessional Approach to Managing Adverse Events of PI3K Inhibitors.

Management of NTM Lung Disease

Presentation transcript:

Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Heart

Checkpoint Inhibition

Incidence of imAEs

Myocarditis

What Is Myocarditis?

Monitoring

Diagnostic Workup

Case 1: Dyspnea

Case 1: Workup

Case 2: Palpitations and Near Syncope

Case 2: Workup

Working With Cardiology

Cardiac MR

Case 2: Wrap-Up

Case 3: Substernal Chest Pain

Case 3: Workup

Case 3: Possible Myocarditis

Management of Myocarditis

Management of Myocarditis in Patients Who Do Not Respond to Steroids

Further Notes on the Management of Myocarditis

Concluding Remarks

Abbreviations

Abbreviations (cont)